# US 8,277,850 B2 · Use of an active ingredient that is obtained from Cyperus esculentus for its anti-aging cutaneous action

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,850 B2
- Document ID: US8277850B2
- Status: Granted
- Kind: B2
- Application number: 12/863,596
- Filed: 2009-01-28
- Published: 2010-11-18
- Granted: 2012-10-02
- Earliest claimed: 2008-01-28
- Assignees: Societe Industrielle Limousine D'Application Biologique
- Inventors: Jean Paufique
- Web page: https://patentgrep.com/patent/US8277850B2

## CPC

- A61K 36/8905: Cyperus (flatsedge)
- A61P 17/00: Drugs for dermatological disorders
- A61P 39/00: General protective or antinoxious agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of treating cutaneous aging using of at least one active ingredient obtained from Cyperus esculentus in a cosmetic and/or dermopharmaceutical composition that is designed to combat cutaneous aging, preferably by working on the specific markers of the dermis. Cosmetic and/or dermopharmaceutical compositions that include an active ingredient that is obtained from Cyperus esculentus, an active ingredient that is obtained from Cyperus esculentus, and its production process.

## Claims

### Claim 1

A method for treating cutaneous aging in a subject in need thereof, consisting essentially of:
administering to the subject's skin a composition consisting essentially of 0.01-20% of a Cyperus esculentus extract;
wherein said extract has:
a dry materials content of between 10 and 250 g/l,
a pH between 3 and 7, and
a total sugar content of between 8 and 240 g/l; and
wherein said extract is able to:
work on the synthesis of at least one specific fibrous molecule of the papillary dermis,
increase the expression of functional collagens XII and/or XVI and/or oxytalan fibers and/or fibrillin-1 fibers of the papillary dermis, and
increase the expression of matrix collagens I and/or VI.
